Stroke Trial, Recruiting NCT06303869 Sponsor: Jorge Gonzalez-Martinez Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06303869
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who had a single stroke (either a blocked-artery stroke or a bleeding stroke) more than 6 months ago that caused difficulty with speech (dysarthria).
  • People between the ages of 18 and 75 years old.
  • People who speak English.
  • People whose speech is affected enough to score below 80% in at least 4 areas of a speech assessment (covering things like how clearly speech can be understood, speaking rate, and voice quality), OR below 80% in at least 3 of those areas combined with a low score on a communication participation questionnaire.

Who may not be able to join:

  • People who decline to take part in the study.
  • People whose brain scans show significant unusual differences in brain structure, or whose stroke affected the thalamus or cerebellum areas of the brain.
  • People whose health is not suitable for a deep brain stimulation (DBS) implant surgery, or who depend heavily on blood-thinning medication.
  • People who are unable to have pre-surgery MRI scans or complete the required assessments before the procedure.
  • People who have a serious illness or condition other than stroke (for example, another neurological condition, cancer, severe heart or lung disease, or kidney failure), or who have significant difficulties with thinking or memory that could affect their ability to participate.
  • People who are pregnant, planning to become pregnant within the next 9 months, or currently breastfeeding.
  • People who are currently taking blood-thinning (anticoagulant) medications.
  • People with severe claustrophobia (fear of enclosed spaces).
  • People who are taking medications for muscle stiffness (anti-spasticity) or seizures (anti-epileptic) during the study period.
  • People considered unsuitable based on results from a psychological symptom questionnaire (BSI-18) and review by the study team.
  • People who score below 12 on an assessment of their ability to understand and sign a consent form.
  • People who cannot have an MRI scan for any reason — including having metal in their body, a cardiac pacemaker, cochlear implant, aneurysm clip, certain types of IUD, or claustrophobia.
  • People taking medications that commonly cause side effects affecting thinking or memory.
  • People with bleeding disorders or problems with blood clotting (for example, from regular aspirin use).
  • People whose speech difficulty is caused by damage to the lower nerve pathways (flaccid dysarthria), rather than stroke-related causes.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jorge Gonzalez-Martinez, MD/PhD, University of Pittsburgh

Phone: 240-441-4216

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Jorge Gonzalez-Martinez
Registry
ClinicalTrials.gov
Start date
20 June 2025
Est. completion
1 November 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Adverse Events; Discomfort and Pain

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov